Liu, Xiangyou
Braun, Gary B.
Qin, Mingde
Ruoslahti, Erkki
Sugahara, Kazuki N.
Article History
Received: 16 January 2017
Accepted: 2 June 2017
First Online: 24 August 2017
Competing interests
: E.R. and K.N.S. have ownership interest (including patents) of DrugCendRInc, which holds a license to the iRGD peptide. The remaining authors declare no competing financial interests.